(Q46025900)
Statements
Bevacizumab and irinotecan for recurrent oligodendroglial tumors (English)
S Taillibert
B Granger
Y Marie
C Carpentier
R Guillevin
A Bellanger
K Mokhtari
A Rousseau
D Psimaras
C Dehais
M Sierra del Rio
Y Meng
F Laigle-Donadey
K Hoang-Xuan
M Sanson